What Does NAD+ Do: Role in Cellular Health

Last reviewed: May 29, 2026

Last updated: May 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that powers energy production in mitochondria and activates repair mechanisms like sirtuins and PARPs. NAD+ availability declines approximately 50% from age 20 to age 50, which correlates with reduced cellular energy capacity and slower DNA repair.

For individuals considering metabolic interventions like GLP-1 therapies or lifestyle modifications, NAD+ status offers valuable context about baseline mitochondrial function. PlexusDx's precision-wellness approach examines how genetic predispositions in energy metabolism and peptide signaling pathways interact with NAD+-dependent processes, supporting more informed conversations with your healthcare provider.

Core Functions of NAD+ in Cellular Metabolism

NAD+ operates as an electron shuttle in glycolysis, the citric acid cycle, and the electron transport chain—processes that convert glucose and fats into ATP (cellular energy). Without adequate NAD+, cells struggle to extract energy efficiently, leading to fatigue and reduced metabolic flexibility.

Beyond energy, NAD+ activates sirtuins (NAD+-dependent enzymes) that regulate cellular stress responses, circadian rhythms, and aging-related processes. NAD+-dependent PARPs repair DNA damage from oxidative stress and inflammation, processes particularly relevant during sustained metabolic changes or weight loss phases.

NAD+ Decline Across the Lifespan and Metabolic Impact

NAD+ levels decrease progressively with age due to increased consumption by stress-response pathways (PARPs, sirtuins) and reduced biosynthesis from dietary precursors. This decline correlates with mitochondrial dysfunction, reduced exercise tolerance, slower recovery, and increased metabolic disease risk.

Research shows NAD+ supplementation (via precursors like NMN or NR) restores NAD+ pools in animal models and early human studies, though clinical evidence in humans remains limited. Age-related NAD+ decline may also reduce your body's capacity to adapt to metabolic interventions like GLP-1 therapy or intensive lifestyle changes.

Age Range	Estimated NAD+ Change	Metabolic Implications
20–30 years	Baseline (100%)	Peak mitochondrial efficiency and ATP production capacity
30–50 years	~50% decline	Reduced energy flexibility; slower recovery from stress or exercise
50–70 years	~60–75% decline	Increased fatigue, impaired DNA repair, slower wound healing
70+ years	~80% decline	Significant metabolic inflexibility; heightened disease risk

NAD+ and Metabolic Flexibility in Weight Management

NAD+-dependent enzymes regulate the switch between carbohydrate and fat oxidation (metabolic flexibility). Adequate NAD+ supports your body's ability to shift between glucose and ketone metabolism, a critical capacity during caloric deficit or fasting-mimetic protocols often paired with GLP-1 therapy.

Individuals with lower baseline NAD+ may experience slower weight loss, reduced exercise capacity, or difficulty sustaining lifestyle changes. Restoring NAD+ bioavailability through precursor supplementation (NMN, NR) or lifestyle interventions (exercise, intermittent fasting, sleep optimization) may support metabolic resilience during treatment phases.

Genetic and Biomarker Context for NAD+ Status

Your capacity to synthesize and utilize NAD+ depends partly on genetic variants in NAD+ biosynthetic pathways (NAMPT, QPRT, NADSYN1) and consumption enzymes (SIRT1, PARP1). Genetic predispositions influence whether you benefit most from precursor supplementation versus lifestyle-based NAD+ optimization.

While PlexusDx's Precision Peptide Genetic Test focuses on GLP-1 and metabolic peptide pathways, NAD+ metabolism intersects with energy sensors (AMPK, mTOR) that influence peptide signaling. Your provider can interpret NAD+ biomarkers (serum or urinary levels, if measured) alongside genetic predispositions to design a more cohesive metabolic strategy that supports both GLP-1 efficacy and overall mitochondrial health.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic pathways (FTO rs9939609, MC4R rs17782313) that influence energy sensing and appetite regulation. These genetic insights may help provide context about your baseline metabolic capacity and how NAD+-dependent processes (mitochondrial ATP production, stress responses) interact with GLP-1 signaling during treatment.

The genetic test does not directly measure NAD+ status or predict exact NAD+ response to supplementation. However, understanding your genetic profile in energy metabolism and peptide pathways should be interpreted with a qualified healthcare provider to assess whether NAD+ optimization may support your overall metabolic response to GLP-1 therapy or other metabolic interventions.

By connecting NAD+ biology to your peptide pathway genetics, a comprehensive evaluation can determine whether NAD+ precursor supplementation (NMN, NR, nicotinamide) aligns with your treatment goals. This personalized approach can support a more informed conversation with your provider about metabolic optimization before, during, and after GLP-1 therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test starts at $99 add-on. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the difference between NAD+ and NADH?

NAD+ (oxidized form) accepts electrons and drives energy-producing reactions; NADH (reduced form) carries electrons to the electron transport chain. Both forms exist in equilibrium, and their ratio affects cellular energy efficiency.

Can I raise my NAD+ levels naturally?

Exercise, intermittent fasting, sleep optimization, and dietary sources (tryptophan, niacin, yeast) support NAD+ availability. NAD+ precursors (NMN, NR, nicotinamide) are available as supplements, though clinical evidence in humans remains limited.

How does NAD+ relate to GLP-1 therapy?

Both NAD+ and GLP-1 regulate mitochondrial function and metabolic flexibility. Optimizing NAD+ status may support your body's ability to adapt to metabolic changes during GLP-1 treatment, though this should be discussed with your provider.

Are NAD+ supplements safe?

NAD+ precursors (NMN, NR) show favorable safety profiles in short-term studies, but long-term human data is limited. Consult your healthcare provider before starting supplementation, especially if you take other medications or have underlying health conditions.

Does the Precision Peptide Genetic Test measure NAD+ status?

No, the test reveals predispositions in GLP-1 and metabolic peptide pathways, not NAD+ biosynthesis. However, genetic insights into energy metabolism may help your provider contextualize NAD+ status and supplementation strategies alongside your GLP-1 treatment plan.

What Does NAD+ Do: Cellular Energy, Aging, and Genetic Predispositions